APOE genotype, ethnicity, and the risk of cerebral hemorrhage

Objective: The apolipoprotein E (APOE) polymorphism is an established risk factor for intracerebral hemorrhage (ICH) that is related to cerebral amyloid angiopathy in the white population. Among Asian populations, although ICH represents up to one third of all strokes and has high rates of mortality and morbidity, the role of the APOE polymorphism has not been well studied. Methods: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) was a randomized, double-blind, placebo-controlled trial of a blood pressure lowering regimen in subjects with prior cerebrovascular disease. APOE status was determined for 5,671 patients, including 2,148 Asians (38%). Results: During the 3.9 years of follow-up, ICH occurred in 99 patients. Overall, carrying an ε2 or ε4 allele of the APOE polymorphism was associated with an adjusted hazard ratio (HRa) of 1.85 (95% CI = 1.24 to 2.76). In Asian patients the risk of ICH for ε2 or ε4 carriers was 2.11 (95% CI = 1.28 to 3.47) and 1.48 (95% CI = 0.76 to 2.87) in Europeans. Carriers of the ε2 or ε4 allele had an increased risk of both incident and recurrent ICH, and both cortical and deep ICH, and most risk estimates were higher in Asians than in Europeans. For both ethnic groups and for subtypes of ICH active treatment more than halved the risk of ICH and the treatment effects were not different in carriers of the ε2 or ε4 allele and in those with the ε3ε3 genotype. Conclusions: There is a strong association between APOE genotype and the risk of intracerebral hemorrhage (ICH). In Asian patients the role of APOE polymorphisms in ICH is much broader than was previously supposed.

[1]  C. Sudlow,et al.  Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  J. Broderick,et al.  Association of Apolipoprotein E4 and Haplotypes of the Apolipoprotein E Gene With Lobar Intracerebral Hemorrhage , 2005, Stroke.

[3]  M. Woodward,et al.  Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial , 2003, Stroke.

[4]  Jun Yang,et al.  Proportion of different subtypes of stroke in China. , 2003, Stroke.

[5]  Eric E. Smith,et al.  Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.

[6]  C. Yang,et al.  Cerebral amyloid angiopathy in aged Chinese: a clinico-neuropathological study , 2003, Acta Neuropathologica.

[7]  J. Szaflarski,et al.  Genetic and Environmental Risk Factors for Intracerebral Hemorrhage: Preliminary Results of a Population-Based Study , 2002, Stroke.

[8]  Berrit C Stroehla,et al.  Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. , 2002, American journal of epidemiology.

[9]  D. Johnston.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack , 2001, The Lancet.

[10]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[11]  S. Greenberg,et al.  Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.

[12]  Y. Kokubo,et al.  Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. , 2000, Stroke.

[13]  J. Nicoll,et al.  Apolipoprotein E Genotype and Cerebral Amyloid Angiopathy‐related Hemorrhage , 2000, Annals of the New York Academy of Sciences.

[14]  K. Furie,et al.  Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. , 2000, The New England journal of medicine.

[15]  E. L. Teng,et al.  ApoE genotype in relation to AD and cholesterol , 1999, Neurology.

[16]  S. Love,et al.  Cerebral Amyloid Angiopathy–Related Hemorrhage Interaction of APOE ε2 With Putative Clinical Risk Factors , 1999 .

[17]  D. Graham,et al.  The Apolipoprotein E ∈2 Allele and the Pathological Features in Cerebral Amyloid Angiopathy-related Hemorrhage , 1999 .

[18]  J. McNeil,et al.  Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. , 1998, Hypertension.

[19]  J. Nicoll,et al.  High frequency of apolipoprotein E ϵ2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage , 1998, Neuroscience Letters.

[20]  S. Greenberg,et al.  Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy , 1998, Neurology.

[21]  T. Ogihara,et al.  Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. , 1997, American journal of hypertension.

[22]  D. Graham,et al.  High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy , 1997, Annals of neurology.

[23]  Bradley T. Hyman,et al.  Apolipoprotein E ε4 Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy , 1996 .

[24]  Zheng-lai Wu,et al.  Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors. , 1995, Stroke.

[25]  B. Hyman,et al.  Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy , 1995 .

[26]  L. Thal,et al.  Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. , 1995, Archives of neurology.

[27]  T. Miyatake,et al.  Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly , 1993, Journal of the Neurological Sciences.

[28]  J. Broderick,et al.  Lobar Hemorrhage in the Elderly: The Undiminishing Importance of Hypertension , 1993, Stroke.

[29]  S. Leung,et al.  Cerebral amyloid angiopathy in Chinese: Incidence and significance , 1991, Clinical Neurology and Neurosurgery.

[30]  D. Sherman,et al.  Stroke in the People's Republic of China. , 1989, Stroke.

[31]  H. Vinters.  Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.

[32]  T. W. Smith,et al.  Intracerebral hemorrhage caused by cerebral amyloid angiopathy: radiographic-pathologic correlation. , 1984, AJNR. American journal of neuroradiology.

[33]  C. Fisher,et al.  PATHOLOGICAL OBSERVATIONS IN HYPERTENSIVE CEREBRAL HEMORRHAGE , 1971, Journal of neuropathology and experimental neurology.

[34]  Fisher Cm.  Pathological observations in hypertensive cerebral hemorrhage. , 1971 .

[35]  Nobuyuki Yasui,et al.  [Intracerebral hemorrhage]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[36]  D. Graham,et al.  The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. , 1999, Journal of neuropathology and experimental neurology.

[37]  B. Hyman,et al.  Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. , 1998, Neurology.

[38]  B T Hyman,et al.  Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. , 1996, Stroke.

[39]  B. Hyman,et al.  Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. , 1995, Annals of neurology.

[40]  John E. Shelton.  People's Republic of China , 1973 .